CTLA4-Fc is a chimeric murine construct consisting of the CD28 homolog
ue CTLA4 and the constant portion of the heavy chain of mouse IgG2a, w
ith a potential to suppress cellular xeno-immune responses. The aim of
this study was to determine the degree of binding of CTLA4 to B7 liga
nds on cells of different species and to use CTLA4-Fc as a tool for th
e study of cross-species CD28-B7 interactions. As assessed by flow cyt
ometry, CTLA4-Fc bound to mouse L-cells and human Epstein Barr virus (
EBV) transformed lymphoblastoid cells and concanavalin A (Con A) or LP
S-stimulated peripheral blood mononuclear cells (PBMC) or splenocytes
from rat, dog, and pig. CTLA4-Fc inhibited the proliferation of Con A-
stimulated PBMC or splenocytes from mouse, rat, dog, and pig, in a dos
e-dependent fashion with approximately 80% inhibition at a concentrati
on of 10 mu g/ml. It did not inhibit the proliferation of Con A-stimul
ated human PBMC, although it did inhibit the human versus human, and h
uman versus pig primed mixed lymphocyte culture (MLC) in a dose-depend
ent fashion. At submitogenic concentrations, purified human T-cells di
d not proliferate after incubation with Con A alone. However, prolifer
ation occurred with the addition of B7 positive L-cells or pig PBMC, b
ut not B7-negative OKT4 cells, Furthermore, CTLA4-Fc inhibited prolife
ration in a dose-dependent fashion. CTLA4-Fc bound to all species test
ed and resulted in inhibition of Con A-stimulated proliferation in the
se species, except for humans, Human T-cells proliferated in response
to co-stimulation with xenogeneic B7, and this could be inhibited by C
TLA4-Fc, suggesting that xenogeneic B7 was capable of providing a func
tionally significant co-stimulatory signal necessary for human T cell
activation in vitro.